Walleye Capital LLC Adc Therapeutics Sa Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.87 - $5.24 $524,191 - $957,059	-182,645 Reduced 26.23%	513,618 $1.97 Million
Q3 2022 Nov 14, 2022	SELL	$4.66 - $10.31 $896,756 - $1.98 Million	-192,437 Reduced 21.65%	696,263 $3.36 Million
Q2 2022 Aug 08, 2022	BUY	$5.96 - $14.99 $3.82 Million - $9.6 Million	640,346 Added 257.84%	888,700 $7.07 Million
Q1 2022 May 16, 2022	BUY	$13.28 - $20.03 $2.69 Million - $4.06 Million	202,876 Added 446.1%	248,354 $3.65 Million
Q4 2021 Mar 03, 2022	BUY	$19.29 - $31.51 $877,270 - $1.43 Million	45,478 New	45,478 $918,000

55.1M

82.7K

31.5K

Ticker ADCT
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,645,296
Market Cap $135M
Description
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.